Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 25, Issue 3, Pages 217-231
Publisher
Bioscientifica
Online
2018-01-04
DOI
10.1530/erc-17-0389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit
- (2017) Alf Spitschak et al. Molecular Cancer
- Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years
- (2017) Reese W. Randle et al. SURGERY
- MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome
- (2017) Francesca Galuppini et al. VIRCHOWS ARCHIV
- Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
- (2017) Loris De Cecco et al. Genes
- Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression
- (2016) Belinda Phipson et al. Annals of Applied Statistics
- Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression
- (2016) Ying-Hsia Chu et al. ENDOCRINE PATHOLOGY
- MicroRNAs associated with small bowel neuroendocrine tumours and their metastases
- (2016) Helen C Miller et al. ENDOCRINE-RELATED CANCER
- MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib
- (2016) Sandra Lassalle et al. Oncotarget
- Management of advanced medullary thyroid cancer
- (2016) Julien Hadoux et al. Lancet Diabetes & Endocrinology
- Data Normalization Strategies for MicroRNA Quantification
- (2015) H. Schwarzenbach et al. CLINICAL CHEMISTRY
- The PDCD4/miR-21 pathway in medullary thyroid carcinoma
- (2015) Gianmaria Pennelli et al. HUMAN PATHOLOGY
- A novel semi-automated in situ hybridisation protocol for microRNA detection in paraffin embedded tissue sections
- (2015) Ambra Vittoria Gualeni et al. JOURNAL OF CLINICAL PATHOLOGY
- Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
- (2015) R.A. Werner et al. MEDICINE
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Corrigendum to “MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET” [FEBS Lett. 588 (2014) 1644-1651]
- (2014) Lijun Duan et al. FEBS LETTERS
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- A lipemia-independent NanoDrop®-based score to identify hemolysis in plasma and serum samples
- (2014) Valentina Appierto et al. Bioanalysis
- Feasibility of circulating miRNA microarray analysis from archival plasma samples
- (2013) Maurizio Callari et al. ANALYTICAL BIOCHEMISTRY
- Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy
- (2013) R. Kurzrock et al. ANNALS OF ONCOLOGY
- Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression?
- (2013) S. Postel-Vinay et al. ANNALS OF ONCOLOGY
- A miRNA signature associated with human metastatic medullary thyroid carcinoma
- (2013) Libero Santarpia et al. ENDOCRINE-RELATED CANCER
- Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
- (2013) Jena Hudson et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The emerging role of miR-375 in cancer
- (2013) Jun-Wei Yan et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive factors that influence the course of medullary thyroid carcinoma
- (2013) Kalliopi Pazaitou-Panayiotou et al. International Journal of Clinical Oncology
- Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
- (2013) Yuji Toiyama et al. JNCI-Journal of the National Cancer Institute
- Nodal metastasis microRNA expression correlates with the primary tumour in MTC
- (2012) Justin S. Gundara et al. ANZ JOURNAL OF SURGERY
- SomaticRASMutations Occur in a Large Proportion of SporadicRET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon
- (2012) A. Boichard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
- (2012) Caterina Mian et al. THYROID
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
- (2011) C. C. Pritchard et al. Cancer Prevention Research
- miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
- (2011) E. Nishikawa et al. CANCER RESEARCH
- MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets
- (2011) D. Abraham et al. CLINICAL CANCER RESEARCH
- High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas
- (2011) Margarida M. Moura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
- (2011) Radha Duttagupta et al. PLoS One
- Youden Index and Optimal Cut-Point Estimated from Observations Affected by a Lower Limit of Detection
- (2008) Marcus D. Ruopp et al. BIOMETRICAL JOURNAL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
- (2008) Anne Laure Giraudet et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
- (2008) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now